Jagsonpal Pharmaceuticals Buyback Record Date is not finalized.
Jagsonpal Pharmaceuticals is a pharmaceutical company engaged in the manufacturing and marketing of branded generic formulations across multiple therapeutic segments. Jagsonpal primarily focuses on the domestic formulations market and has built a presence in therapy areas such as gastroenterology, dermatology, pain management, anti-infectives, and nutritional supplements.
The company’s product portfolio includes tablets, capsules, syrups, ointments, and other formulations that are prescribed by healthcare professionals across India. Jagsonpal has developed several well-established brands over the years, including Lyser-D, Zymar, and Raricap, which are widely used for gastrointestinal disorders, nutritional deficiencies, and related therapeutic needs. Jagsonpal Pharmaceuticals distributes its products through a nationwide network of distributors, stockists, and pharmacies, supported by a field force of medical representatives.
Jagsonpal Pharmaceuticals Buyback Record Date, Other Details
| Jagsonpal Pharmaceuticals Buyback Dates | Coming soon |
| Jagsonpal Pharmaceuticals Buyback Price | INR 250 per share |
| Market Price on Buyback Approval | INR 189.80 per share |
| Buyback Premium on Market Price | 31.71% |
| Buyback Offer Size (Shares) | 16,00,000 shares |
| Buyback Offer Size (Amount) | INR 40 crore |
| Offer Type | Tender |
| Promoter Participation | Nil |
| Face Value | INR 2 per share |
| Listing At | BSE, NSE |
Jagsonpal Pharmaceuticals Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 9 March 2026 |
| Buyback Approval Date | 12 March 2026 |
| Public Announcement of Buyback | Coming soon |
| Jagsonpal Pharmaceuticals Buyback Record Date | Coming soon |
| Buyback Opening Date | Coming soon |
| Buyback Closing Date | Coming soon |
| Cut-off Date to receive completed tender forms by Registrar | Coming soon |
| Verification Date by the Registrar | Coming soon |
| Return of unaccepted shares by Registrar | Coming soon |
| Extinguishment of accepted shares | Coming soon |
Jagsonpal Pharmaceuticals Buyback 2026 Documents
Letter of Offer
Public Announcement
Board Approval
Upcoming Share Buyback
Jagsonpal Pharmaceuticals Buyback Entitlement Ratio
| Shareholder Category | Entitlement Ratio | Entitlement Ratio (in %) |
| Small Shareholders (less than INR 2 Lakh on record date) | – | 7.70* |
| General category (for all other Eligible Shareholders) | – | – |
A small shareholder is defined as a shareholder who holds shares worth less than INR 2,00,000 as of the record date.
Jagsonpal Pharmaceuticals Financial Performance
| FY 2022 | FY 2023 | FY 2024 | |
| Total Income | 237 | 209 | 269 |
| Total Expenses | 203 | 186 | 218 |
| Net Income | 27 | 22 | 55 |
Calculation of Investment in Buyback
| Maximum market value of a shareholder as on record date | INR 2,00,000 |
| Buyback price per share | INR 250 |
| Maximum shares for small shareholders (2,00,000/250) | 800 shares * |
| The closing price of the stock as of 12 March 2026 | INR 189.80** |
| Maximum amount invested in buyback (INR 189.80 x 800 shares) | INR 1,51,840 |
** For simplicity, we have considered the price on the buyback approval date
Jagsonpal Pharmaceuticals Buyback Acceptance Ratio
| Shares Tendered | Buyback Entitlement | Acceptance ratio | Buyback Profit | Profit in % |
| 800 | 56 | 56 (100%) | 3,371.2 | 2.22 |
| 800 | 56 | 112 (200%) | 6,742.4 | 4.44 |
| 800 | 56 | 168 (300%) | 10,113.6 | 6.66 |
Registrar of Jagsonpal Pharmaceuticals Buyback 2026
Coming soon
Manager of Jagsonpal Pharmaceuticals Buyback 2026
Coming soon
The Process to Participate in Jagsonpal Pharmaceuticals Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Frequently Asked Questions
What are Jagsonpal Pharmaceuticals buyback dates?
Jagsonpal Pharmaceuticals’ buyback opens on April 2026 and closes on April 2026.
Which type of buyback is Jagsonpal Pharmaceuticals’ buyback offer?
Jagsonpal Pharmaceuticals’ buyback is a tender offer.
What is Jagsonpal Pharmaceuticals buyback price?
Jagsonpal Pharmaceuticals’ buyback price is INR 250 per share.
What is the Jagsonpal Pharmaceuticals buyback record date?
Jagsonpal Pharmaceuticals buyback record date is coming soon.
How to participate in Jagsonpal Pharmaceuticals share buyback?
Jagsonpal Pharmaceuticals share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.
Rajat Bhati has a strong technical background and 5 years of experience in the stock market. He focuses on equity research, technical analysis, IPO valuations, and risk management, helping investors make clearer, data-backed decisions. Today, he works full-time to educate people about the opportunities in IPO market.
